EZH2 and diffuse midline glioma: We find in particular that H3.3K27M, an alteration found in the vast majority of diffuse midline gliomas, acts to impair PRC2 activity throughout the genome, causing losses of H3K27me3 at essentially every target region and transcriptomic changes resembling milder forms of those observed in isogenic cells lacking the core PRC2 subunits EZH2 and EED.